Skip to content
Screener

Inspire Medical Systems INSP Net Change in Cash

Net Change in Cash at other companies

ResMed logo
ResMedRMD
-$191.28M-169%
LivaNova logo
LivaNovaLIVN
-$23.09M+84.1%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$35.76M+241%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$6.18M-146%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$10.46M-35.5%
Globus Medical logo
Globus MedicalGMED
-$53.21M+77.0%

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.7B-26.6%
Enterprise value$1.63B-27.3%
P/E13×-30.7×
P/S1.9×-0.8×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Reported directly by Inspire Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: Inspire Medical Systems’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001609550-26-000023
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Payment of taxes on net share settlement of equity awards(7,591)(19,192)
Net cash (used in) financing activities(7,482)(87,760)
Effect of exchange rate on cash1(252)
(Decrease) in cash and cash equivalents(5,881)(96,268)
Cash and cash equivalents at beginning of period104,813150,150
Cash and cash equivalents at end of period$98,932$53,882
Supplemental cash flow information
Cash paid for interest$16

Item 1. Financial Statements.

FAQ

What is Inspire Medical Systems's net change in cash?
Inspire Medical Systems (INSP) reported net change in cash of -$5.88M in Q1 2026.
How has Inspire Medical Systems's net change in cash changed year-over-year?
Inspire Medical Systems's net change in cash increased by 93.9% year-over-year, from -$96.27M to -$5.88M.
What is the long-term trend for Inspire Medical Systems's net change in cash?
Over 3 years (2021 to 2024), Inspire Medical Systems's net change in cash has grown at a 16.7% compound annual growth rate (CAGR), from $23.95M to -$38.03M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about Inspire Medical Systems's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude